Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTopuk, Savas
dc.contributor.authorAkyuva, Yener
dc.contributor.authorKaraaslan, Numan
dc.contributor.authorMutlu, Cagri A.
dc.contributor.authorYilmaz, Ibrahim
dc.contributor.authorIsyar, Mehmet
dc.contributor.authorSirin, Duygu Yasar
dc.contributor.authorAkkaya, Semih
dc.contributor.authorOzbek, Hanefi
dc.contributor.authorMahirogullari, Mahir
dc.date.accessioned2025-10-16T15:27:57Z
dc.date.issued2017
dc.identifier.doi10.2174/1389201018666170615083455
dc.identifier.otherWOS:000407701900010
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8595
dc.publisherBENTHAM SCIENCE PUBL LTD
dc.sourceCURRENT PHARMACEUTICAL BIOTECHNOLOGY
dc.subjectControlled release
dc.subjectdrug delivery systems
dc.subjectmiRNA
dc.subjectosteosarcoma
dc.subjectsiRNA
dc.subjectpharmacogenomics
dc.titleIs it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS